Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare Lispro Mixture Therapy (insulin lispro 50/50 given
three times daily with meals) to Glargine Basal-Bolus Therapy (insulin glargine daily with
the addition of insulin lispro given three times daily with meals). The study is also
comparing two different methods for adjusting the dose of insulin.